Back To: Home : Featured Technology : Stem Cell
CLICK HERE FOR WHAT'S NEW IN:
 

Athersys, Fast Forward to collaborate on MS treatment
December 2011
SHARING OPTIONS:

CLEVELAND, Ohio—Athersys Inc. has announced an alliance with Fast Forward LLC, a nonprofit subsidiary of the National Multiple Sclerosis Society, to fund the development of Athersys' MultiStem adult stem cell platform for the treatment of multiple sclerosis (MS). Fast Forward will provide up to $640,000 in funding for the program's advancement to clinical stage, and will provide funding for the preclinical testing of MultiStem in murine models of MS to support the submission of an investigation new drug application to the FDA, with an aim of securing authorization for a clinical trial treating patients diagnosed with chronic progressive MS with MultiStem. If certain pre-determined development milestones are reached, Fast Forward will receive milestone payments from Athersys. Athersys will collaborate with Case Western Reserve University School of Medicine under the leadership of Dr. Robert H. Miller, vice president of research on this project.


Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.